Skip to content

A Community-Based Pre-Trial Study on Communication and Shared Decision-Making Intervention for Cardiovascular Disease Risk in Patients with Diabetes

A Community-Based Pre-Trial Study on Communication and Shared Decision-Making Intervention for Cardiovascular Disease Risk in Patients with Diabetes

Status
Active, not recruiting
Phases
Early Phase 1
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2400094403
Enrollment
Unknown
Registered
2024-12-23
Start date
2024-12-27
Completion date
Unknown
Last updated
2025-01-06

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Type 2 Diabetes

Interventions

General Practitioner Group:Conduct a 1.5-day training course on risk communication and shared decision-making for patients with diabetes.
Type 2 Diabetes Patient Group:Receive three outpatient consultations on diabetes cardiovascular risk communication and shared decision-making provided by general practitioners.

Sponsors

Peking University First Hospital
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 75 Years

Inclusion criteria

Inclusion criteria: Inclusion Criteria (Physician Version): 1. Age >=18 years; 2. Registered as a general practitioner; 3. Have undergone standardized training for general practice residents or transitional training; 4. Engaged in clinical work in the community for more than 1 year; 5. Signed family physician contracts (with patients who have signed diabetes contracts); 6. No plans for external training or study in the next year; 7. Capable of completing all course training programs. Inclusion Criteria (Patient Version): 1. Male or female =18 years; 2. Permanent residents of the community (for at least 6 months); 3. Diagnosed with Type 2 diabetes according to the Chinese Diabetes Guidelines; 4. Medical insurance designated institution is at the Gaobeidian Community Health Service Center in Beijing.

Exclusion criteria

Exclusion criteria: Exclusion Criteria (Physician Version): 1. Unwilling to participate in the study, accept related training, and sign informed consent. Exclusion Criteria (Patient Version): 1. Diagnosed with Type 1 diabetes according to the Chinese Diabetes Guidelines; 2. Medical insurance designated institution is not at the Gaobeidian Community Health Service Center in Beijing; 3. Concurrent malignant tumors; 4. Presence of cognitive abnormalities and communication barriers; 5. In the acute complication phase of diabetes; 6. Have diabetes with combined atherosclerotic cardiovascular diseases (ASCVD), pregnancy, or planning to become pregnant; 7. Unwilling to participate in the study and unwilling to sign informed consent.

Design outcomes

Secondary

MeasureTime frame
Fasting blood glucose;blood fat;glycosylated hemoglobin;body mass index;World Health Organization Five-item Well-Being Index, WHO-5;Problem Areas in Diabetes Scale;Patient Health Questionnaire-9;C-DES-SF;Medication Compliance Scale;Doctor Patient Relationship Depth Scale;

Primary

MeasureTime frame
Cardiovascular Disease Risk Attitude and Belief Questionnaire (ABCD);

Countries

China

Contacts

Public ContactMi Yao

Peking University First Hospital

mi.yao@bjmu.edu.cn+86 180 0129 7801

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026